Literature DB >> 24337182

Fatty acid synthase overexpression in adult testicular germ cell tumors: potential role in the progression of non-seminomatous germ cell tumors.

Kosuke Miyai1, Keiichi Iwaya, Tomohiko Asano, Seiichi Tamai, Osamu Matsubara, Hitoshi Tsuda.   

Abstract

Overexpression of fatty acid synthase (FASN), which is a key enzyme responsible for the endogenous synthesis of fatty acids, and its association with multistep progression have been demonstrated in various human malignant tumors. We aimed to clarify the potential role of FASN overexpression in the development and progression of adult testicular germ cell tumors (TGCTs). From the primary sites of a cohort of 113 TGCT cases, we obtained 221 histological components: 53 intratubular germ cell neoplasias, unclassified (IGCNUs), 84 seminomas, 32 embryonal carcinomas, seven choriocarcinomas, 21 yolk sac tumors, and 24 teratomas. Samples were analyzed for overexpression of FASN by immunohistochemistry. Intensities of immunoreactivity and the fraction of positive cells were classified into each four categories (intensity, 0 to 3; fraction, 0-10 % = 1, 11-50 % = 2, 51-80 % = 3, and >80 % = 4). The overall score was determined by multiplication of both scores and overall scores greater than 6 were considered FASN overexpression. On a component basis, FASN overexpression was detected in 8 % of seminomas but not in IGCNUs (0 %) and was detected frequently in non-seminomatous germ cell tumors (NSGCTs) (88 % of embryonal carcinomas, all choriocarcinomas, 81 % of yolk sac tumors, and 54 % of teratomas). There were no cases of a mixed tumor (i.e., a tumor with multiple histological components) that overexpressed FASN in seminoma components but not in co-existing NSGCT components, suggesting sequential progression. Our immunohistochemical data suggest that FASN overexpression occurs as a late event during the progression from IGCNUs/seminomas to NSGCTs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24337182     DOI: 10.1007/s00428-013-1525-y

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  38 in total

Review 1.  Testicular germ-cell cancer.

Authors:  G J Bosl; R J Motzer
Journal:  N Engl J Med       Date:  1997-07-24       Impact factor: 91.245

2.  Epidermal growth factor receptor expression and activation in nonseminomatous germ cell tumors.

Authors:  M Moroni; S Veronese; R Schiavo; O Carminati; B S Sorensen; M Gambacorta; S Siena
Journal:  Clin Cancer Res       Date:  2001-09       Impact factor: 12.531

3.  Carcinoma in situ of testicular tissue adjacent to malignant germ-cell tumors: a study of 105 cases.

Authors:  G K Jacobsen; O B Henriksen; H von der Maase
Journal:  Cancer       Date:  1981-06-01       Impact factor: 6.860

4.  International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.

Authors: 
Journal:  J Clin Oncol       Date:  1997-02       Impact factor: 44.544

5.  Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection.

Authors:  B P Hermans; C J Sweeney; R S Foster; L E Einhorn; J P Donohue
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

6.  Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells.

Authors:  Javier A Menendez; Luciano Vellon; Inderjit Mehmi; Bharvi P Oza; Santiago Ropero; Ramon Colomer; Ruth Lupu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-02       Impact factor: 11.205

7.  Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma.

Authors:  Akio Horiguchi; Tomohiko Asano; Takako Asano; Keiichi Ito; Makoto Sumitomo; Masamichi Hayakawa
Journal:  J Urol       Date:  2008-07-18       Impact factor: 7.450

8.  Differences in the regulation of adipose tissue and liver lipogenesis by carbohydrates in humans.

Authors:  Frédérique Diraison; Vivienne Yankah; Dominique Letexier; Eric Dusserre; Peter Jones; Michel Beylot
Journal:  J Lipid Res       Date:  2003-02-01       Impact factor: 5.922

9.  Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma.

Authors:  L Z Milgraum; L A Witters; G R Pasternack; F P Kuhajda
Journal:  Clin Cancer Res       Date:  1997-11       Impact factor: 12.531

10.  Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.

Authors:  Weibo Zhou; P Jeanette Simpson; Jill M McFadden; Craig A Townsend; Susan M Medghalchi; Aravinda Vadlamudi; Michael L Pinn; Gabriele V Ronnett; Francis P Kuhajda
Journal:  Cancer Res       Date:  2003-11-01       Impact factor: 12.701

View more
  4 in total

1.  Interaction between fatty acid synthase and human epidermal growth receptor 2 (HER2) in osteosarcoma cells.

Authors:  Xin Hua Long; Kai Zhao; Guo Mei Zhang; Yang Zhou; Rong Ping Zhou; Zhi Li Liu; Zhi Hong Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

2.  The glucose-sensing transcription factor MLX balances metabolism and stress to suppress apoptosis and maintain spermatogenesis.

Authors:  Patrick A Carroll; Brian W Freie; Pei Feng Cheng; Sivakanthan Kasinathan; Haiwei Gu; Theresa Hedrich; James A Dowdle; Vivek Venkataramani; Vijay Ramani; Xiaoying Wu; Daniel Raftery; Jay Shendure; Donald E Ayer; Charles H Muller; Robert N Eisenman
Journal:  PLoS Biol       Date:  2021-10-20       Impact factor: 9.593

3.  Differential expression of Mediator complex subunit MED15 in testicular germ cell tumors.

Authors:  Niklas Klümper; Isabella Syring; Sven Perner; Felix Bremmer; Anne Offermann; David Adler; Wenzel Vogel; Stefan C Müller; Jörg Ellinger; Arne Strauß; Heinz Joachim Radzun; Philipp Ströbel; Johannes Brägelmann
Journal:  Diagn Pathol       Date:  2015-09-17       Impact factor: 3.196

4.  PFKFB4 Overexpression Facilitates Proliferation by Promoting the G1/S Transition and Is Associated with a Poor Prognosis in Triple-Negative Breast Cancer.

Authors:  Yu-Chen Cai; Hang Yang; Hong-Bo Shan; Hui-Fang Su; Wen-Qi Jiang; Yan-Xia Shi
Journal:  Dis Markers       Date:  2021-06-09       Impact factor: 3.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.